van Gunsteren Job Leonard's Form 4/A amendment
AmendedBalchem Corp (BCPC) · filed Sep 20, 2022
- Accession no.
- 0001140361-22-034002
- Filed
- Sep 20, 2022
- Trade date
- Aug 5, 2022
- Filing delay
- 46 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Aug 9, 2022
This filing lists 1 derivative transaction. It carries over 2 transactions from the original filing that it did not restate. Open-market sales total $333.9K. It was filed 46 days after the trade.
This amendment restates part of 0001140361-22-028897 (filed Aug 9, 2022). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| van Gunsteren Job LeonardCIK 0001906287 | Officer (SVP and GM, Specialty Products) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2022 | Common Stock | MOption exerciseDisposed | −2,629 | $0.00 | $0 | 0 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001140361-22-028897 (filed Aug 9, 2022).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2022 | Common Stock | MOption exerciseAcquired | +2,629 | $50.32 | +$132,291.28 | 4,059 | Direct | |
| Aug 5, 2022 | Common Stock | SSaleDisposed | −2,629 | $127.01F2 | −$333,909.29 | 1,430 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F2
This transaction was executed in multiple sales ranging from $127.00 to $127.05 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Stock options that vested 20% on February 26, 2015, 40% on February 26, 2016, and 40% on February 26, 2017, and are exercisable.
Remarks
This Form 4/A amends the original Form 4 filed on August 9, 2022, which inadvertently omitted from Table II (due to administrative error) the disposition of stock options that were exercised on August 5, 2022. Note: The title of the reporting person on this Form 4/A reflects his title as of the date of filing of this Form 4/A.